We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This guide is about infections that occur in people who inject drugs (PWID).
People are urged to seek advice from healthcare professionals if they feel they have become dependent on or addicted to codeine linctus.
OPSS is leading a fresh campaign to raise awareness among parents and carers about potential hazards to children associated with swallowing small magnets, button batteries, loose/small toy parts and imitation food.
How the MHRA makes decisions on what is a medicinal product (borderline products).
How a marketing authorisation holder should report a defect with a veterinary medicine.
What you need to know about and do to comply with the law and keep consumers safe.
How to use a cost effectiveness analysis to evaluate your digital health product.
Guidance for manufacturers, importers and distributors on the Product Security and Telecommunications Infrastructure Act 2022 and Regulations 2023.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
How to use a cost benefit analysis to evaluate your digital health product.
Find out if you need to pay Tobacco Products Duty if you make or import tobacco, how much it is and when you can suspend or defer payment.
Check the tariff classification for flavour pods.
Resources to help anyone developing or running a digital health product to conduct an evaluation.
Applying for an individual domestic drugs licence to prescribe cocaine, diamorphine and dipipanone for the treatment of addiction.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
How to use a crossover randomised controlled trial to evaluate your digital health product.
If you're advertising or marketing, including direct marketing, you must be accurate and honest and follow the advertising codes of practice
Information for consumers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.